In last trading session, Clearside Biomedical Inc (NASDAQ:CLSD) saw 0.33 million shares changing hands with its beta currently measuring 2.10. Company’s recent per share price level of $0.88 trading at $0.02 or 1.67% at ring of the bell on the day assigns it a market valuation of $67.92M. That closing price of CLSD’s stock is at a discount of -87.5% from its 52-week high price of $1.65 and is indicating a premium of 20.45% from its 52-week low price of $0.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.12 million shares which gives us an average trading volume of 184.09K if we extend that period to 3-months.
For Clearside Biomedical Inc (CLSD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Clearside Biomedical Inc (NASDAQ:CLSD) trade information
Upright in the green during last session for gaining 1.67%, in the last five days CLSD remained trading in the green while hitting it’s week-highest on Wednesday, 05/14/25 when the stock touched $0.88 price level, adding 6.3% to its value on the day. Clearside Biomedical Inc’s shares saw a change of -7.48% in year-to-date performance and have moved 2.34% in past 5-day. Clearside Biomedical Inc (NASDAQ:CLSD) showed a performance of 1.05% in past 30-days. Number of shares sold short was 0.25 million shares which calculate 1.61 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 10.40% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 12.46% while estimates for its earnings growth in next 5 years are of -2.08%.
Clearside Biomedical Inc (NASDAQ:CLSD)’s Major holders
Insiders are in possession of 13.09% of company’s total shares while institution are holding 14.40 percent of that, with stock having share float percentage of 16.57%. Investors also watch the number of corporate investors in a company very closely, which is 14.40% institutions for Clearside Biomedical Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CLSD for having 2.84 million shares of worth $3.69 million. And as of 2024-06-30, it was holding 3.8003 of the company’s outstanding shares.
The second largest institutional holder is ROSALIND ADVISORS, INC., which was holding about 2.59 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.4692 of outstanding shares, having a total worth of $3.37 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.97 shares of worth $1.73 million or 2.55% of the total outstanding shares. The later fund manager was in possession of 783.85 shares on Dec 31, 2024 , making its stake of worth around $0.69 million in the company or a holder of 1.01% of company’s stock.
